Related references
Note: Only part of the references are listed.Novel Regulation of Cardiac Metabolism and Homeostasis by the Adrenomedullin-Receptor Activity-Modifying Protein 2 System
Takahiro Yoshizawa et al.
HYPERTENSION (2013)
Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons
Vu C. Dang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Cardioprotective Effect of Apelin-13 on Cardiac Performance and Remodeling in End-Stage Heart Failure
Wataru Koguchi et al.
CIRCULATION JOURNAL (2012)
Hypertension and vascular calcification: a vicious cycle?
Marcello Rattazzi et al.
JOURNAL OF HYPERTENSION (2012)
Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure
Giuseppe Distefano et al.
ITALIAN JOURNAL OF PEDIATRICS (2012)
Prehypertension, Racial Prevalence and Its Association With Risk Factors: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study
Stephen P. Glasser et al.
AMERICAN JOURNAL OF HYPERTENSION (2011)
Effect of Apelin-Apelin Receptor System in Postischaemic Myocardial Protection: A Pharmacological Postconditioning Tool?
Raffaella Rastaldo et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Increased expression of insulin-like growth factor-binding protein-3 is implicated in erectile dysfunction in two-kidney one-clip hypertensive rats after propranolol treatment
Zhang-Yan Zhou et al.
ASIAN JOURNAL OF ANDROLOGY (2011)
Reduced circulating apelin in essential hypertension and its association with cardiac dysfunction
Monika Przewlocka-Kosmala et al.
JOURNAL OF HYPERTENSION (2011)
Apelin Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells
Peng-Fei Shan et al.
PLOS ONE (2011)
Acute Cardiovascular Effects of Apelin in Humans Potential Role in Patients With Chronic Heart Failure
A. G. Japp et al.
CIRCULATION (2010)
Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist
Xavier Iturrioz et al.
FASEB JOURNAL (2010)
Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy
Camille Foussal et al.
FEBS LETTERS (2010)
Fibrosis in hypertensive heart disease: molecular pathways and cardioprotective strategies
Atta U. Shahbaz et al.
JOURNAL OF HYPERTENSION (2010)
G Protein-Coupled Receptor-Associated Sorting Protein 1 Regulates the Postendocytic Sorting of Seven-Transmembrane-Spanning G Protein-Coupled Receptors
Elisabeth Moser et al.
PHARMACOLOGY (2010)
[Pyr1]Apelin-13 Identified as the Predominant Apelin Isoform in the Human Heart Vasoactive Mechanisms and Inotropic Action in Disease
Janet J. Maguire et al.
HYPERTENSION (2009)
Abnormal fluid homeostasis in apelin receptor knockout mice
Emma M. Roberts et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemiareperfusion injury
James C. Simpkin et al.
BASIC RESEARCH IN CARDIOLOGY (2007)
The MEK/ERK cascade: From signaling specificity to diverse functions
Yoav D. Shaul et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Overexpression of β1-adrenoceptors in adult rat ventricular myocytes enhances CGP 12177A cardiostimulation:: implications for 'putative' β4-adrenoceptor pharmacology
CJ Lewis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway
DJ Hausenloy et al.
CARDIOVASCULAR RESEARCH (2004)
Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction
MM Chen et al.
CIRCULATION (2003)
Share Paper
